With the development of nanomaterials, the application of nanocarriers has become increasingly common in medical research, especially in the fields of drug delivery and gene delivery.
Currently, in the research of nano-drug delivery systems, there exist issues such as poor biocompatibility, short blood circulation lifetime, insufficient active targeting, and low permeability through biological membranes.
In recent years, with the development of biomedicine, the cell membrane-mediated nano-drug delivery system based on biomimetic technology has become a promising delivery strategy for targeted tumor therapy using nanotechnology.